Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum.

In Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl diphosphate, central intermediates in the biosynthesis of isoprenoids, occurs via the methylerythritol phosphate (MEP) pathway. Fosmidomycin is a specific inhibitor of the second enzyme of the MEP pathway, 1-deoxy-D-xylulose-5-phosphate reductoisomerase. We analyzed the effect of fosmidomycin on the levels of each intermediate and its metabolic requirement for the isoprenoid biosynthesis, such as dolichols and ubiquinones, throughout the intraerythrocytic cycle of P. falciparum. The steady-state RNA levels of the MEP pathway-associated genes were quantified by real-time polymerase chain reaction and correlated with the related metabolite levels. Our results indicate that MEP pathway metabolite peak precede maximum transcript abundance during the intraerythrocytic cycle. Fosmidomycin-treatment resulted in a decrease of the intermediate levels in the MEP pathway as well as in ubiquinone and dolichol biosynthesis. The MEP pathway associated transcripts were modestly altered by the drug, indicating that the parasite is not strongly responsive at the transcriptional level. This is the first study that compares the effect of fosmidomycin on the metabolic and transcript profiles in P. falciparum, which has only the MEP pathway for isoprenoid biosynthesis.

[1]  T. Begley,et al.  Structural insights into the mechanism of the PLP synthase holoenzyme from Thermotoga maritima. , 2006, Biochemistry.

[2]  M. Aebi,et al.  The dolichol pathway of N-linked glycosylation. , 1999, Biochimica et biophysica acta.

[3]  M. Rodríguez-Concepcíon,et al.  The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs. , 2004, Current pharmaceutical design.

[4]  Jonathan Schug,et al.  Drug‐induced alterations in gene expression of the asexual blood forms of Plasmodium falciparum , 2003, Molecular microbiology.

[5]  J. Liao,et al.  REVIEW Metabolic Engineering of Isoprenoids , 2001 .

[6]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[7]  Jochen Wiesner,et al.  Fosmidomycin for malaria , 2002, The Lancet.

[8]  M. Cassera,et al.  The Methylerythritol Phosphate Pathway Is Functionally Active in All Intraerythrocytic Stages of Plasmodium falciparum* , 2004, Journal of Biological Chemistry.

[9]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[10]  V. J. Peres,et al.  N-Linked Glycoproteins Are Related to Schizogony of the Intraerythrocytic Stage in Plasmodium falciparum* , 1996, The Journal of Biological Chemistry.

[11]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[12]  A. Boronat,et al.  Bioinformatic and molecular analysis of hydroxymethylbutenyl diphosphate synthase (GCPE) gene expression during carotenoid accumulation in ripening tomato fruit , 2003, Planta.

[13]  Manuel Llinás,et al.  Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains , 2006, Nucleic acids research.

[14]  J. Selbig,et al.  Parallel analysis of transcript and metabolic profiles: a new approach in systems biology , 2003, EMBO reports.

[15]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[16]  T. Chojnacki,et al.  The biological role of dolichol. , 1988, The Biochemical journal.

[17]  Patricia De la Vega,et al.  Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle , 2003, Science.

[18]  A. Bacher,et al.  Biosynthesis of isoprenoids via the non-mevalonate pathway , 2004, Cellular and Molecular Life Sciences CMLS.

[19]  D. Carucci,et al.  Transcripts of developmentally regulated Plasmodium falciparum genes quantified by real-time RT-PCR. , 2002, Nucleic acids research.

[20]  A. Halestrap,et al.  Characterization of the Enhanced Transport of L- and D-Lactate into Human Red Blood Cells Infected with Plasmodium falciparum Suggests the Presence of a Novel Saturable Lactate Proton Cotransporter (*) , 1995, The Journal of Biological Chemistry.

[21]  J. Derisi,et al.  The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum , 2003, PLoS biology.

[22]  L. Carretero-Paulet,et al.  Regulation of carotenoid biosynthesis in plants: evidence for a key role of hydroxymethylbutenyl diphosphate reductase in controlling the supply of plastidial isoprenoid precursors. , 2004, The Plant journal : for cell and molecular biology.

[23]  Shunji Takahashi,et al.  Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis , 1998 .

[24]  J. Liao,et al.  Metabolic engineering of isoprenoids. , 2001, Metabolic engineering.

[25]  J. Wiesner,et al.  Short-Course Regimens of Artesunate-Fosmidomycin in Treatment of Uncomplicated Plasmodium falciparum Malaria , 2005, Antimicrobial Agents and Chemotherapy.

[26]  M. Sinensky,et al.  Recent advances in the study of prenylated proteins. , 2000, Biochimica et biophysica acta.

[27]  H. Lichtenthaler,et al.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.

[28]  Hartmut K. Lichtenthaler,et al.  THE 1-DEOXY-D-XYLULOSE-5-PHOSPHATE PATHWAY OF ISOPRENOID BIOSYNTHESIS IN PLANTS. , 1999, Annual review of plant physiology and plant molecular biology.

[29]  J. Sacchettini,et al.  Creating Isoprenoid Diversity , 1997, Science.

[30]  J. Wiesner,et al.  Fosmidomycin plus Clindamycin for Treatment of Pediatric Patients Aged 1 to 14 Years with Plasmodium falciparum Malaria , 2006, Antimicrobial Agents and Chemotherapy.

[31]  Christopher J. Tonkin,et al.  Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast , 2004, Nature Reviews Microbiology.

[32]  K. Kirk,et al.  Transport of lactate and pyruvate in the intraerythrocytic malaria parasite, Plasmodium falciparum. , 2001, The Biochemical journal.

[33]  M. Rohmer.  The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. , 1999, Natural product reports.

[34]  M. Rodríguez-Concepcíon,et al.  Carotenoid biosynthesis during tomato fruit development: regulatory role of 1-deoxy-D-xylulose 5-phosphate synthase. , 2000, The Plant journal : for cell and molecular biology.

[35]  John E Hyde,et al.  Quantitative proteomics of the human malaria parasite Plasmodium falciparum and its application to studies of development and inhibition , 2004, Molecular microbiology.

[36]  S. Müller,et al.  Vitamin B6 Biosynthesis by the Malaria Parasite Plasmodium falciparum , 2006, Journal of Biological Chemistry.

[37]  L. Carretero-Paulet,et al.  1-Deoxy-D-xylulose 5-phosphate reductoisomerase and plastid isoprenoid biosynthesis during tomato fruit ripening. , 2001, The Plant journal : for cell and molecular biology.

[38]  David L. Tabb,et al.  A proteomic view of the Plasmodium falciparum life cycle , 2002, Nature.

[39]  F. McLafferty,et al.  Reconstitution and biochemical characterization of a new pyridoxal-5'-phosphate biosynthetic pathway. , 2005, Journal of the American Chemical Society.